Boundless Bio Inc.
BOLD
Get informed when a big investor buys or sells
+ FollowMarket Cap$32.57M
Close$
$-1.39
196.8% downside
Current Fair Value
196.8% downsideOvervalued by 196.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $32.57 Million |
|---|---|
| Enterprise Value | $63.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.6 |
| Beta | 0.95 |
| Outstanding Shares | 22,407,000 |
Return
| Return on Equity | -64.82% |
|---|---|
| Return on Assets | -39.72% |
| Return on Invested Capital | -47.15% |
Valuation & Multiples
| P/E Ratio | -0.58 |
|---|---|
| PEG | 4.15 |
| Price to Sales | - |
| Price to Book Ratio | 0.48 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.02 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | 0.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-0.60
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 37.95%▼ 1.27% |
|---|---|
| Total Invested | $9.33M▼ 11.42% |
| Investors Holding | 36▲ 1.00% |
ESG Score
No data